Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
46 participants
INTERVENTIONAL
2015-02-28
2016-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vibration and Post-traumatic Osteoarthritis Risk Following ACL Injury
NCT04875052
Immediate Effects of Whole Body Vibration on Neuromuscular Performance of Quadriceps Femoris and Balance
NCT02416362
The Effect of Whole Body Vibration After ACLR
NCT05254054
The Effects of Whole-body Vibration on Increasing Quadriceps Strength in Patients With ACL Ruptures
NCT04988828
Whole Body Vibration on Running Biomechanics
NCT02851316
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vibration group
The vibration group (Vibration at 50 Hz) will hold an exercise protocol on the vibration platform (model Power Plate® pro5 ™), which is to stay on on affected limb, with the knee held in 40 ° of flexion, hands together to the body and the trunk in the erect position. Altogether, the participant will perform 11 sets of 30 seconds with a rest interval of 30 seconds between sets. The knee angle will be monitored throughout the protocol by the second reviewer with a goniometer so that there is no change in it. During the sets the vibrating platform will be turned on at a vibration frequency of 50 Hz.
Vibration at 50 Hz
During the exercise protocol, the vibration platform will be turned on at a vibration frequency of 50 Hz.
Control group
The control group (No vibration) will hold an exercise protocol on the vibration platform, which is to stay on affected limb, with the knee held in 40 ° of flexion, hands together to the body and the trunk in the erect position. Altogether, the participant will perform 11 sets of 30 seconds with a rest interval of 30 seconds between sets. The knee angle will be monitored throughout the protocol by the second reviewer with a goniometer so that there is no change in it. The vibrating platform will remain off throughout intervention.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vibration at 50 Hz
During the exercise protocol, the vibration platform will be turned on at a vibration frequency of 50 Hz.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Without pain or inflammatory signs in the joint assessed;
* Absence of labyrinthine and neurological disorders;
* Range of motion greater than 90o flexion and complete extension;
* No previous history of lower limb surgery before the lesion;
* Be performing Physical Therapy
Exclusion Criteria
* Presence of pain at the time of the tests;
* Complication preventing collection.
18 Years
45 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidade Federal do Rio Grande do Norte
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jamilson Simões Brasileiro
Professor of Physiotherapy
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
07042915KA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.